Volume : 09, Issue : 10, October – 2022



Authors :

Dr. Bandar Abdullah Alagl , Dr. Shaden Ali Almohaimeed , Mohammed Ali Almohaimeed , Sara Zakaria Aldossari , Dr. Meshari Talal Alanazi , Bandar Ibrahim ALjammaz, Dr. khadeja jawad Dawood

Abstract :

Background: A significant public health issue and a significant risk factor for the emergence of diabetes complications is poor and insufficient glycemic control among type 2 diabetes patients. Social scientists and medical professionals are both concerned about the rising prevalence of non-adherence to medical treatment. As a result, a sizable portion of patients do not benefit sufficiently from medical care, which leads to subpar health outcomes, a decreased quality of life, and higher healthcare costs.
Objectives: This study aims to assess the extent of anti-diabetic drug adherence and determine factors associated with non-adherence among patients with type 2 diabetes mellitus in Saudi Arabia.
Methods: For article selection, the PubMed database was used. All relevant articles relevant with our topic and other articles were used in our review. Other articles that were not related to this field were excluded. The data was extracted in a specific format that was reviewed by the group members.
Conclusion: The study included 13 studies in different region in Saudi Arabia. Moderated level of adherence was noted generally in Saudi Arabia. The highest levels of adherence was reported in Tabuk. Young age and polypharmacy were significantly correlated with adherence. Despite the availability of numerous new medication classes, increased patient education efforts, and targeted interventions that address adherence, medication adherence in T2D remains low.
Keywords: diabetes, adherence, compliance, barriers, Saudi Arabia, T2DM, T1DM

Cite This Article:

Please cite this article in Bandar Abdullah Alagl et al, Adherence To Anti-Diabetic Medications Among Saudi Diabetic Patients – A Systematic Review., Indo Am. J. P. Sci, 2022; 09(10).

Number of Downloads : 10


1. International Diabetes Federation Middle East, and North Africa 2015.
2. Federation ID. IDF Diabetes atlas. 8th edn Middle East and North Africa, 2017.
3. Al-Daghri NM, Al-Attas OS, Alokail MS, et al.. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med 2011;9:76 10.1186/1741-7015-9-76
4. Gonzalez JS, Schneider HE, Wexler DJ, Psaros C, Delahanty LM, Cagliero E, et al. Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care. 2013 Apr;36(4):831–7
5. Jemal A, Abdela J, Sisay M. Adherence to Oral Antidiabetic Medications among Type 2 Diabetic (T2DM) patients in chronic ambulatory wards of Hiwot Fana specialized University Hospital, Harar, Eastern Ethiopia: a cross sectional study. J Diabetes Metab. 2017 Jan;8(1):721–29.
6. Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Preference and Adherence. 2013 Jun 17;7:525–530.
7. Sankar UV, Lipska K, Mini GK, Sarma PS, Thankappan KR. The adherence to medications in diabetic patients in rural Kerala, India. Asia Pac J Public Health. 2015 Mar;27(2):NP513–23
8. Divya S, Nadig P. Factors contributing to non-adherence to medication among type 2 diabetes mellitus in patients attending tertiary care hospital in south India. Asian J Pharm Clin Res. 2015 Feb;8(2):274–276.
9. Sherman JJ, Davis L, Daniels K. Addressing the polypharmacy conundrum. US Pharmacist. 2017 Jun;42(6):HS14–20.
10. Abebaw M, Messele A, Hailu M, Zewdu F. Adherence and associated factors towards antidiabetic medication among type ii diabetic patients on follow-up at university of gondar hospital, Northwest Ethiopia. Adv Nurs. 2016;2016:1-7.
11. AlQarni, Khaled et al. “Assessment of Medication Adherence in Saudi Patients With Type II Diabetes Mellitus in Khobar City, Saudi Arabia.” Frontiers in pharmacology vol. 10 1306. 8 Nov. 2019, doi:10.3389/fphar.2019.01306
12. AlShayban, Dhfer Mahdi et al. “Association of Disease Knowledge and Medication Adherence Among Out-Patients With Type 2 Diabetes Mellitus in Khobar, Saudi Arabia.” Frontiers in pharmacology vol. 11 60. 20 Feb. 2020, doi:10.3389/fphar.2020.00060
13. Alqarni, Abdullah M et al. “Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia – a cross-sectional survey.” Patient preference and adherence vol. 13 63-71. 24 Dec. 2018, doi:10.2147/PPA.S176355
14. Ahmed, Nahid Osman et al. “Adherence to oral hypoglycemic medication among patients with diabetes in Saudi Arabia.” International journal of health sciences vol. 11,3 (2017): 45-49.
15. Balkhi, Bander et al. “Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.” BMJ open vol. 9,7 e029280. 23 Jul. 2019, doi:10.1136/bmjopen-2019-029280
16. Prabahar, Kousalya et al. “Assessment of Medication Adherence in Patients with Chronic Diseases in Tabuk, Kingdom of Saudi Arabia.” Journal of research in pharmacy practice vol. 9,4 196-201. 11 Jan. 2021, doi:10.4103/jrpp.JRPP_20_97
17. Alyami, Mohsen et al. “Illness Perceptions, HbA1c, And Adherence In Type 2 Diabetes In Saudi Arabia.” Patient preference and adherence vol. 13 1839-1850. 25 Oct. 2019, doi:10.2147/PPA.S228670
18. Alsayed, Khalid A, and Medhat Khalifa Ghoraba. “Assessment of diabetic patients’ adherence to insulin injections on basal-bolus regimen in diabetic care center in Saudi Arabia 2018: Cross sectional survey.” Journal of family medicine and primary care vol. 8,6 (2019): 1964-1970. doi:10.4103/jfmpc.jfmpc_276_19
19. Alodhaib, Ghaida et al. “Qualitative Exploration of Barriers to Medication Adherence Among Patients with Uncontrolled Diabetes in Saudi Arabia.” Pharmacy (Basel, Switzerland) vol. 9,1 16. 11 Jan. 2021, doi:10.3390/pharmacy9010016
20. Al Harbi, Turki J et al. “Adherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Saudi Arabia.” Saudi medical journal vol. 36,2 (2015): 221-7. doi:10.15537/smj.2015.2.9603
21. Alhabib, Mohammed Y et al. “Medication Adherence Among Geriatric Patients with Chronic Diseases in Riyadh, Saudi Arabia.” Patient preference and adherence vol. 16 2021-2030. 8 Aug. 2022, doi:10.2147/PPA.S363082
22. Khan, Ataur R et al. “Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia.” Journal of family & community medicine vol. 19,1 (2012): 26-32. doi:10.4103/2230-8229.94008
23. Khayyat, Yara A Jr et al. “Adherence to Hypoglycemic Agents in Type 2 Diabetes Mellitus: A Cross-Sectional Study.” Cureus vol. 14,2 e22626. 26 Feb. 2022, doi:10.7759/cureus.22626
24. World Health Organization: Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003
25. Arifulla M, John LJ, Sreedharan J, Muttappallymyalil J, Basha SA. Patients’ adherence to anti-diabetic medications in a Hospital at Ajman, UAE. The Malaysian journal of medical sciences : MJMS. 2014;21(1):44–9.
26. Abebaw M, Messele A, Hailu M, Zewdu F. Adherence and associated factors towards antidiabetic medication among type II diabetic patients on follow-up at University of Gondar Hospital, Northwest Ethiopia. Advances in Nursing. 2016;8579157:2016.
27. Bagonza J, Rutebemberwa E, Bazeyo W. Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Serv Res. 2015;15:168.
28. Huber CA, Reich O. Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland. Patient preference and adherence. 2016;10:1803–9.
29. Rwegerera GM, Moshomo T, Gaenamong M, Oyewo TA, Gollakota S, Mhimbira FA, et al. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alex J Med. 2018;54(2):103–9.
30. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299-1307. Published 2016 Jul 22. doi:10.2147/PPA.S106821
31. Karter A, Parker M, Moffet H, Ahmed A, Schmittdiel J, Selby J. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res 2009;44(5 Pt 1):1640–61. https://doi.org/10.1111/j.1475-6773.2009.00989.x
32. Gadkari A, McHorney C. Medication nonfulfillment rates and reasons: narrative systematic review. Curr Med Res Opin 2010;26(3):683–705. https://doi.org/10.1185/03007990903550586
33. Farmer A, Kinmonth A, Sutton S. Measuring beliefs about taking hypoglycaemic medication among people with type 2 diabetes. Diabet Med 2006;23(3):265–70.
34. Larkin M, Capasso V, Chen C, et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ 2008;34(3):511–17. https://doi.org/10.1177/0145721708317869
35. Brundisini F, Vanstone M, Hulan D, DeJean D, Giacomini M. Type 2 diabetes patients’ and providers’ differing perspectives on medication nonadherence: a qualitative meta-synthesis. BMC Health Serv Res 2015; 15(1):516. https://doi.org/10.1186/s12913-015-1174-8
36. Tiv M, Viel J, Mauny F, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population-based study. PLoS One 2012;7(3):e32412. https://doi.org/10.1371/journal.pone.0032412
37. Claxton A, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23(8):1296–310. https://doi.org/10.1016/s0149-2918(01)80109-0
38. Hauber A, Mohamed A, Johnson F, Falvey H. Treatment preferences and medication adherence of people with type 2 diabetes using oral glucose-lowering agents. Diabet Med 2009;26(4):416–24. https://doi.org/10.1111/j.1464-5491.2009.02696.x
39. Walz L, Pettersson B, Rosenqvist U, Deleskog A, Journath G, Wändell P. Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes. Patient Prefer Adherence 2014;8:593–601. https://doi.org/10.2147/PPA.S58781
40. McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S. Comparison of medication adherence and persistence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 2018;20(4):1040–3. https://doi.org/10.1111/dom.13160
41. McGovern A, Hinton W, Calderara S, Munro N, Whyte M, de Lusignan S. A class comparison of medication persistence in people with type 2 diabetes: a retrospective observational study. Diabetes Ther 2018;9(1):229–42. https://doi.org/10.1007/s13300-017-0361-5
42. Negarandeh R, Mahmoodi H, Noktehdan H, Heshmat R, Shakibazadeh E. Teach back and pictorial image educational strategies on knowledge about diabetes and medication/dietary adherence among low health literate patients with type 2 diabetes. Prim Care Diabetes. 2013;7(2):111–118. doi:10.1016/j.pcd.2012.11.001